Jami Kinnucan, M.D., is a Senior Associate Consultant in the Section of Gastroenterology and Hepatology at the Mayo Clinic in Jacksonville, Florida. Prior to relocating to the Mayo Clinic in 2022, she was an Assistant Professor of Medicine at the University of Michigan and severed as Director of Inflammatory Bowel Disease Education as well as Association Program Director for Gastroenterology and Hepatology fellowship training. Dr. Kinnucan has expertise in the evaluation and management of patients with inflammatory bowel disease (IBD) including ulcerative colitis and Crohn's disease, as well as in the management of complex cases of microscopic colitis. In addition, she has expertise in the evaluation and management of patients who have undergone ileoanal pouch anastomosis (IPAA or J-pouch) and who are currently pregnant with IBD. Dr. Kinnucan is frequently an invited speaker a regional and national conferences talking on the diagnosis and management of IBD. She has research interests in the use of cannabis in IBD, anxiety and depression in IBD as well as looking outcomes in at risk patient populations, including Chaldean Americans, with IBD. Dr. Kinnucan is dedicated to both patient and provider education and the advancement of women in the field of Gastroenterology. She started the Women in GI Committee at the University of Michigan, currently serves as Co-Chair for Women in IBD Task Force for the Crohn's and Colitis Foundation National Scientific Advisory Committee and a member of the American College of Gastroenterology Women in Gastroenterology Committee. She also serves as a medical editor for SELF Magazine. To stay up to date on some of the latest education in IBD, follow her on Twitter at @ibdgijami.

Doctors in the Division of Gastroenterology and Hepatology at Mayo Clinic specialize in preventing, diagnosing and treating digestive tract and liver disorders. These mainly include conditions involving the pancreas, liver, gallbladder, esophagus, stomach, small intestine and colon. With 13 specialty groups and more than 140 digestive disease specialists on staff, the Division of Gastroenterology and Hepatology at Mayo Clinic is one of the largest and most deeply experienced in the world.

 Cohen BL, Gallinger ZR, Ha C, Holuba SD, Hou JK, Kinnucan JA, Mahadevan U, Moss AC, Raffals LE, Regueiro M, Szigethy E, Wolf D, Dubinsky MC, Anish Patel A, Sha BJ, Ehrlich OG, Stillman BC, Susano MT, Hanauer SB: Development of Entrustable Professional Activities for Advanced Inflammatory Bowel Disease Fellowship Training in the United States Submitted for publication IBD Journal Epub ahead of Print: Epub ahead of Print, 2019.

 Abou-Hanna J, Owens S, Kinnucan JA, Mian, Shazad, Kolars J: Resuscitating the Socratic Method: Student and faculty perspectives on posing probing questions during clinical teaching Academic Medicine Epub ahead of Print: Epub ahead of Print, 2019.

 Riehl M, Kinnucan J, Chey B, Stidham R. Nuances of the psychogastroenterology patient: A predictive model for gastrointestinal quality of life improvement. APT July 2019.

 Kinnucan, J, Binion, D, Cross, R, Evans, E, Harlen, K, Matarese, L, Mullins, A, O’Neal, B, Reiss, M, Scott, F, Weaver, A, Rosenberg, J. Inflammatory Bowel Disease Care Referral Pathway. Gastroenterology July 2019.

 Berinstein JA, Steiner CA, Regal RE, Allen JI, Kinnucan JAR, Stidham RW, Waljee AK, Bishu S, Aldrich LB, Higgins PDR. Efficacy of Induction Therapy with High-intensity Tofacitinib in 4 Patients with Acute Severe Ulcerative Colitis. Clin Gastroenterol Heptol. Nov 2018.

 Swaminath A, Berlin EP, Cheifetz A, Hoffenberg E, Kinnucan J, Wingate L, Buchanan S, Zmeter N, Rubin DT. The Role of Cannabis in the Management of Inflammatory Bowel Disease: A Review of Clinical, Scientific, and Regulatory Information: Commissioned by the Crohn’s and Colitis Foundation. Inflamm Bowel Dis. October 2018.

 Kinnucan J. Use of Medical Cannabis in Patients with Inflammatory Bowel Disease. Gastroenterology & Hepatology. November 2018.

 Christensen B, Micic D, Gibson P, Yarur A, Bellaguarda E, Corsello P, Gaetano JN, Kinnucan J, Rao VL, Singh S, Rubin DT, Pekow J. Vedolizumab in patients with concurrent primary sclerosing cholangitis and inflammatory bowel disease does not improve liver biochemistry but is safe and effective for the bowel disease. APT. March 2018.

 Cleveland NK, Kinnucan J, Rubin DT. Prevention of Colorectal Cancer in Inflammatory Bowel Disease Using Advanced Technologies. Chapter in Inflammatory Bowel Disease: Diagnostics and Therapeutics, 3rd Edition, Cohen, R, Eds, 2017.

 Kinnucan J, Tomal J, Rubin DT. U.S Patients with Ulcerative Colitis Do Not Have a Decreased Risk of Diverticulosis. Inflamm Bowel Dis. 2015 Sep; 21(9): 2154-7. PMID: 26197447.

 Rubin DT and Kinnucan J. Should I Use Chromoendoscopy In My Surveillance Colonoscopy In Inflammatory Bowel Disease? How and Which Agent? Would Narrow-Band Imaging Be An Alternative For This? Curbside Consultation in IBD: 49 Clinical Questions, 2nd Edition, Rubin, DT, 2015.

 Rubin DT, Hou D, Kinnucan J et al. Inflammation Is an Independent Risk Factor for Colonic Neoplasia in Patients with Ulcerative Colitis: A Case-Control Study. Clin Gastroenterol Hepatol 2013 Dec: 11(12): 1601-8. PMID: 23872237.

 Kinnucan J, Rubin DT, Ali T. Sleep in IBD: Are We Just Waking Up? Journal of Gastroenterol & Hepatol , 2013 Nov; 9(11): 718-27. PMID: 24764789.

 Kinnucan J and Hanauer SB. Reassessing the risks and benefits of thiopurines in Crohn’s disease. Clin Gastroenterol Hepatol. 2013 Jun; 11(4):395-7. PMID: 23333707.

 Gawron AJ, Rothe J, Fought AJ, Fareeduddin A, Toto E, Boris L, Kahrilas PJ, Pandolfino JE. Many patients continue using proton pump inhibitors after negative results from tests for reflux disease. Clin Gastroenterol Hepatol. 2012 Jun; 10(6):620-5. PMID: 22366177.

 Kwaitek MA, Hirano I, Karhrilas PJ, Rothe JA, Luger D, Pandolfino JE. Mechanical Properties of the Esophageal Body in Eosinophilic Esophagitis. Gastroenterology 2011. Jan: 140 (1):82-90. PMID: 20858491.

 Rubin DT, Rothe JA. The Peri-Appendiceal Red Patch in Ulcerative Colitis: Review of the University of Chicago Experience. Digestive Diseases and Sciences 2010. Dec: `55(12):3495-501. PMID: 20936357.

 Pekow JR, Hetzel JT, Rothe JA, Hanauer SB, Turner JR, Hart J, Noffsinger A, Huo D, Rubin DT. Outcomes after surveillance of Low Grade and Indefinite Dysplasia in patients with Ulcerative Colitis. Inflammatory Bowel Diseases 2010 16 (8):1352-1356. PMID: 20027656.

 Rubin DT, Rothe JA. New Findings in the Diagnosis and Prevention of Colorectal Cancer in IBD. Chapter in Inflammatory Bowel Disease: Diagnostics and Therapeutics, 2nd Edition, Cohen, R, Eds, 2010.

 Rubin DT, Rothe JA, Hetzel JT, Cohen RD, Hanauer SB. Are dysplasia and colorectal cancer endoscopically visible in patients with ulcerative colitis? Gastrointestinal Endoscopy 2007 65: 1005-1006. PMID:17451704.